Sign in Subscribe
Pharmaceutical industry

Global Pharmaceutical Giants Engage in Historic Merger Talks

Strategic Insights

— 1 min read

Regional news sources reported on the emergence of a major pharmaceutical deal between British giants SmithKline Beecham PLC and Glaxo Wellcome PLC. The potential combination, which would create the world's largest pharmaceutical company, is currently at the negotiation stage. Financial details have not been disclosed, but if a merger is finalized, it would surpass the previous record set by WorldCom's acquisition of MCI Communications Corp.

Key Takeaways:

  • SmithKline Beecham and Glaxo Wellcome are discussing a massive corporate merger that would create the world's largest pharmaceutical company, with a combined market value of approximately $166 billion.
  • The proposed merger would surpass the previous record set by WorldCom's acquisition of MCI Communications Corp. for $37 billion.
  • SmithKline shareholders would hold 40.5% of the new company's stock, while Glaxo Wellcome shareholders would hold 59.5%.
  • The companies have announced that talks have already reached specific levels, indicating a serious commitment to the deal.
  • WorldCom's recent acquisition of Brooks Fiber Properties Inc. for $2.4 billion marks a significant expansion into local telecommunications services.
  • SmithKline's previous talks with American Home Products Corp. have ended without agreement, marking a significant shift in their merger strategies.

Statistics:

  • The combined market value of SmithKline Beecham and Glaxo Wellcome is approximately $166 billion.
  • The proposed merger would be the largest corporate merger in history, surpassing WorldCom's acquisition of MCI Communications Corp. by $29 billion.
  • SmithKline shareholders would hold 40.5% of the new company's stock, while Glaxo Wellcome shareholders would hold 59.5%.
  • WorldCom's acquisition of MCI Communications Corp. has a stock value of about $37 billion.
  • Brooks Fiber Products Inc. had revenue of $35.8 million for the three months ended September 30.

Sources:

  • Allen Organ Co. of Macungie dividend announcement (no date)
  • SmithKline Beecham PLC and Glaxo Wellcome PLC press release (no date)
  • WorldCom Inc. press release (no date)
  • MCI Communications Corp. acquisition announcement (no date)

Read more